157 related articles for article (PubMed ID: 9308027)
1. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice.
Santos AR; Calixto JB
Neuropeptides; 1997 Aug; 31(4):381-9. PubMed ID: 9308027
[TBL] [Abstract][Full Text] [Related]
2. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
[TBL] [Abstract][Full Text] [Related]
4. Effect of the tachykinin receptor antagonists, SR 140333, FK 888, and SR 142801, on capsaicin-induced mouse ear oedema.
Inoue H; Nagata N; Koshihara Y
Inflamm Res; 1996 Jun; 45(6):303-7. PubMed ID: 8814463
[TBL] [Abstract][Full Text] [Related]
5. Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig.
Corboz MR; Fernandez X; Rizzo CA; Tozzi S; Monahan ME; Hey JA
Auton Autacoid Pharmacol; 2003 Feb; 23(1):79-93. PubMed ID: 14565542
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice.
Sakurada T; Katsumata K; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M
Eur J Pharmacol; 1993 Sep; 242(1):47-52. PubMed ID: 7693495
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
8. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice.
Santos AR; Calixto JB
Neurosci Lett; 1997 Oct; 235(1-2):73-6. PubMed ID: 9389599
[TBL] [Abstract][Full Text] [Related]
10. Differential blockade by tachykinin NK1 and NK2 receptor antagonists of bronchoconstriction induced by direct-acting agonists and the indirect-acting mimetics capsaicin, serotonin and 2-methyl-serotonin in the anesthetized guinea pig.
Buckner CK; Liberati N; Dea D; Lengel D; Stinson-Fisher C; Campbell J; Miller S; Shenvi A; Krell RD
J Pharmacol Exp Ther; 1993 Dec; 267(3):1168-75. PubMed ID: 8263778
[TBL] [Abstract][Full Text] [Related]
11. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin (NK1, NK2 and NK3) receptor, transient receptor potential vanilloid 1 (TRPV1) and early transcription factor, cFOS, mRNA expression in rat tissues following systemic capsaicin treatment.
Kunde DA; Crawford A; Geraghty DP
Regul Pept; 2013 May; 183():35-41. PubMed ID: 23499799
[TBL] [Abstract][Full Text] [Related]
13. Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors.
Mazzone SB; Geraghty DP
Br J Pharmacol; 1999 May; 127(2):473-81. PubMed ID: 10385248
[TBL] [Abstract][Full Text] [Related]
14. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
17. Involvement of endogenous tachykinins and CGRP in the motor responses produced by capsaicin in the guinea-pig common bile duct.
Patacchini R; Barthó L; De Giorgio R; Lénárd L; Stanghellini V; Barbara G; Lecci A; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):344-53. PubMed ID: 10543438
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
19. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
Culman J; Klee S; Ohlendorf C; Unger T
J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
